Subscribe for full access
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Recommendation Rating
1
1
2
3
4
5
1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL
Analysts’ Price Targets
Mean 2.19
Low: 2.19
High: 2.19
Total Analysts: 1
Company Profile
Aptamer Group plc is a developer of Optimer binders in the life sciences industry. It offers custom Optimer selection and development services. It delivers aptamer-based solutions to its customer bases for a range of therapeutic, diagnostic, and target-binding applications. It develops Optimer binders for therapeutics, diagnostics, bioprocessing, and research applications. The Optimer platform delivers aptamer tools that enables researchers and developers across the spectrum of the life sciences. Optimer binders has developed for a range of applications, including therapeutic inhibitors and modulators, drug delivery vehicles, protein purification and separation, biomarker screening and validation, in vitro research, quality control analysis, pharmacokinetic and drug assays, and in vitro diagnostic assays. Optimer act as agonists, antagonists, or cell-type-specific targeting moieties for the delivery of therapeutic agents to target cells and tissues in the treatment of disease.
We do our best to screen stocks as accurately as possible. Please let us know in the Community if you spot an error or find something questionable. Jazaak Allahu khairan.
